Pimentel-Rentería, A. A., Cantú de León, D. F., De la Cruz, E. N., Suárez, D., Segura, M. R., Núñez, J. G., & Delgado-Roche, L. (2025). Safety and tolerability of a bevacizumab biosimilar (Effivia®) in adult Mexican patients with cancer: A multicenter, observational, prospective clinical study. Frontiers in drug discovery, 1. https://doi.org/10.3389/fddsv.2025.1591991
Chicago Style (17th ed.) CitationPimentel-Rentería, Alberto Alfonso, David Francisco Cantú de León, Eliseo Neftalí De la Cruz, David Suárez, Manuel Rodulfo Segura, José Gustavo Núñez, and Livan Delgado-Roche. "Safety and Tolerability of a Bevacizumab Biosimilar (Effivia®) in Adult Mexican Patients with Cancer: A Multicenter, Observational, Prospective Clinical Study." Frontiers in Drug Discovery 2025: 1. https://doi.org/10.3389/fddsv.2025.1591991.
MLA (9th ed.) CitationPimentel-Rentería, Alberto Alfonso, et al. "Safety and Tolerability of a Bevacizumab Biosimilar (Effivia®) in Adult Mexican Patients with Cancer: A Multicenter, Observational, Prospective Clinical Study." Frontiers in Drug Discovery, 2025, p. 1, https://doi.org/10.3389/fddsv.2025.1591991.
